Glucagon-like peptide 1 receptor agonists and thyroid cancer: is it the time to be concerned?

Glucagon-like peptide 1 receptor agonists (GLP-1RAs) have changed considerably the management of type 2 diabetes (T2D). However, recently published data from retrospective cohort studies suggest that chronic exposure to GLP-1RAs in T2D may increase the risk of papillary and medullary thyroid cancer....

Descrición completa

Detalles Bibliográficos

Principais autores:	Giuseppe Lisco, Anna De Tullio, Olga Disoteo, Giuseppina Piazzolla, Edoardo Guastamacchia, Carlo Sabbà, Vincenzo De Geronimo, Enrico Papini, Vincenzo Triggiani
Formato:	Artigo
Idioma:	Inglês
Publicado:	Bioscientifica 2023-10-01
Series:	Endocrine Connections
Assuntos:	dipeptidyl peptidase iv glucagon-like peptide 1 receptor agonist incretin system medullary thyroid cancer papillary thyroid cancer
Acceso en liña:	https://ec.bioscientifica.com/view/journals/ec/12/11/EC-23-0257.xml
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!